National Advisory Commission for long-term care proposed — without providers … DOJ suggests ADA updates for government websites, mobile apps … Study defines disparities in memory care … Billings...
More news for Friday, Sept. 2
Sep 01, 2016
Test of experimental Alzheimer’s drug finds progress against brain plaques … MIT start-up tests virtual reality at Brookdale community … Researchers find link between chronic pain, anxiety...
Kim Campbell shares ‘rest of the story’ on caregiving in closing NIC conference session
By
Kimberly Bonvissuto
Oct 16, 2020
During the late stages of her husband’s struggle with Alzheimer’s disease, Kim Campbell said she “truly feared I was going to become the second victim of the disease.”
New partnership makes family-facility interactions less burdensome for LTC caregivers
By
Aaron Dorman
Apr 05, 2024
A new partnership aims to help facilitate easier communication between families and senior living facilities.
‘Smart’ pillbox won’t let seniors or their caregivers forget their daily doses, company promises
By
Aaron Dorman
Dec 12, 2023
A new “smart” pillbox system can help older adults, their families and their caregivers coordinate to maintain proper medication regimens.
75 percent of not-for-profit aging service providers need more relief funds: LeadingAge survey
By
Amy Novotney
Apr 02, 2021
Approximately three-fourths of not-for-profit long-term senior housing and aging service providers report that when they add up all they have received through the Provider Relief Fund and all other pandemic-related...
Pill’s approval could be a senior living game-changer
By
John O'Connor
Nov 16, 2017
Something happened Monday that could greatly improve medication adherence among senior living residents and others.
‘Pet therapy’ could be putting residents, others in danger
By
Alyssa Salela
Jun 20, 2017
As “pet therapy” programs become more popular, a new study finds that senior living communities often deviate from animal visitation guidelines meant to protect residents, staff, visitors and...
Alzheimer’s disease in Down syndrome similar to autosomal dominant form
May 25, 2022
Age at onset and mortality for Alzheimer’s disease in people with Down syndrome were comparable with fully penetrant form of the disease.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.